User Ratings Didn't Catch Blood Pressure App Inaccuracies

Share this content:
User Ratings Didn't Catch Blood Pressure App Inaccuracies
User Ratings Didn't Catch Blood Pressure App Inaccuracies

THURSDAY, June 21, 2018 (HealthDay News) -- User reviews and ratings of a popular, yet inaccurate, blood pressure-measuring mobile app were largely positive, according to a study published online June 7 in the Journal of the American Medical Informatics Association.

Timothy B. Plante, M.D., from the University of Vermont in Colchester, and colleagues evaluated iTunes app reviews for Instant Blood Pressure v1.2.3. Reviews were downloaded and assessed for themes.

The researchers found that common themes included perceived accuracy (42 percent of all reviews), inaccuracy (10 percent), and convenience (34 percent). Its star rating was a mean of 4.8 and median of 5.0 for perceived accuracy. Disclaimers were ineffective at preventing medical use of the app. The authors note that these findings support the need for more rigorous regulatory review of apps prior to their release.

"Physicians need to be careful; if you're saying you personally use an app, people will trust it," Plante said in a statement. "Our take-home message to health care providers is to make sure you hold apps to the highest standards, and not just give out recommendations willy-nilly for apps that you think are neat. And consumers should be skeptical of reviews from self-proclaimed health professionals in product reviews."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Lyme-Bearing Ticks More Widespread in U.S. Than Thought

Lyme-Bearing Ticks More Widespread in U.S. Than Thought

Disease-carrying ticks were detected in 83 counties where they'd never been found before

Availability of Generic Antivirals for Hepatitis B Increasing

Availability of Generic Antivirals for Hepatitis B Increasing

Drop in median price of WHO-prequalified generic tenofovir from $208 to $32 from 2004 to 2016

Visual Function Deficits Up in Developmental Dyslexia

Visual Function Deficits Up in Developmental Dyslexia

Increased prevalence of deficits in visual function versus typically developing school-age children

is free, fast, and customized just for you!




Already a member?

Sign In Now »